Vaccinex to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

NEXT STORY
Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test
PREV STORY
University of Calgary Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect Announces $6.94 Million in Funding from CARB-X to Support Development of Amurin Platform Against All Gram-negative ESKAPE Pathogens

author_avatar
NASDAQ Market News

Antios Therapeutics Continues Building Experienced Executive Team with Appointments of Katie Laessig, M.D., as SVP, Global Regulatory Affairs and Karen Fusaro as SVP, Clinical Operations

author_avatar
NASDAQ Market News

Rexahn Phase 2a Combination Study of RX-3117 and Abraxane® in First-line Metastatic Pancreatic Cancer Patients Advances to Second Stage

Routine Safety Monitoring Committee Review Confirmed No Dose Reductions NecessaryROCKVILLE, Md., May 15, 2018 ...

author_avatar
NASDAQ Market News